Fasting at intervals makes you long-lasting and helps chemotherapy

Fasting is good , doctors say, it fights aging and lengthens life. According to authoritative experts and the results of their experiments published by the American scientific journal Cell Stem Cell fasting makes long-lived and is very useful for patients who are undergoing chemotherapy to purify themselves from toxic substances.

The published article contains the words of the coordinator of the medical staff who worked on the experiments: Professor Longo, director of the Institute of Longevity at the University of Southern California in Los Angeles, who stated that "prolonged periods of fasting, under the control of specialists, they cause changes in the immune system and stimulate the renewal of stem cells ".



At this institute, research on aging has been carried out since the 1960s. Volunteers have been subjected to fasting for four months for four months.

Health
FROM THE HEALTH CHANNEL
Bucharest, pretends to be a British surgeon: in fact, he is from Venice and only has a middle school diploma
Bucharest, pretends to be a British surgeon: in fact, he is from Venice and only has a middle school diploma
by Vincenzo Camaggio
FOLLOW THE HEALTH CHANNEL
Follow the Health Channel to receive all the latest Health news and interact with a community of enthusiasts.
AD

The yeasts and mice were also studied and then the study was tested on humans, the basic analysis from which it all started are the growth factors related to the sugars among other things.

The novelty of this research is of great importance for the results in the fight against cancer with chemotherapy, the study shows that fasting also helps subjects undergoing cycles of chemotherapy to purify, Longo says about it: "We believe that this practice on food promotes the elimination of abnormal cells, precursors of cancer cells ".



The research will continue in the coming months, with another 64 volunteers aged 20 to 70 with fast periods of 4-5 days at intervals of one month. Valter Longo (46 years old) the professor who directed the research has Calabrian origins, studied at the University of Texas and then started working in California, has nevertheless decided to return to Italy to manage the Firc Institute of Molecular Oncology (Ifom) based in Milan, a laboratory in which it will coordinate a team of 12 experts dealing with senility.